LP looks like it's probably going to be declared the kind of the second causal biomarker for atherosclerotic cardiovascular disease. The previous interventions that have all been on the major LDL lowering drugs that we have really don't directly target LP a little A. It seems to be primarily driven by genetics. There's very little evidence that we have that diet that makes a kind of a meaningful difference to LP little A.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode